Escolar Documentos
Profissional Documentos
Cultura Documentos
MAY/JUN 2012Vol.
Vol.38
38No.
No.1 3 Your partner in paediatric
and O&G practice
JOURNAL OF PAEDIATRICS, OBSTETRICS & GYNAECOLOGY
IN PRACTICE
JOURNAL WATCH
ISSN 1016-0124
(INDONESIA)
GYNAECOLOGY
Endometriosis
OBSTETRICS
Hyperemesis,
Gastrointestinal &
Liver Disorders in
Pregnancy
PAEDIATRICS
CME ARTICLE
Current Management of
2 SK
P
Antenatal Hydronephrosis
An Update
www.jpog.com
Get your copy of JPOG and Medical Progress today and earn SKP IDI
MAY/JUN 2012
Vol. 38 No. 3
Journal Watch
91
Go to www.jpog.com or
Scan the QR code to download now!
JOURNAL OF PAEDIATRICS, OBSTETRICS & GYNAECOLOGY
MAY/JUN 2012
Vol. 38 No. 3
Review Articles
Gynaecology
93 Endometriosis
Endometriosis is a very complex gynaecological condition characterized by the presence of ectopic
endometrial tissue outside the uterine cavity and is frequently associated with debilitating pelvic pain
and infertility. The management of endometriosis can be challenging and should be tailored to each
individuals circumstances.
Francesca Raffi, Saad Amer
93 Review Articles
Obstetrics
105
Publisher
Ben Yeo Enquiries and Correspondence PUBLISHER: Journal of Paediatrics, Obstetric & Gynaecology (JPOG) is
published 6 times a year by UBM Medica, a division of United Business Media.
Publication Manager CIRCULATION: JPOG is a controlled circulation for medical practitioners
Marisa Lam China Indonesia Thailand in South East Asia. It is also available on subscription to members of allied
professions. SUBSCRIPTION: The price per annum is US$42 (surface mail,
Deputy Managing Editor Yang Xuan Hafta Hasibuan, Sri Damayanti, Wipa Sriwijitchok students US$21) and US$48 (overseas airmail, students US$24); back issues
Greg Town Tel: (86 21) 6157 3888 Ritta Pamolango Tel: (66 2) 741 5354 US$8 per copy. EDITORIAL MATTER published herein has been prepared by
Associate Editor Email: enquiry.cn@ubmmedica.com Tel: (62 21) 729 2662 Email: enquiry.th@ubmmedica.com professional editorial staff. Views expressed are not necessarily those of UBM
Medica. Although great care has been taken in compiling and checking the
Grace Ling Email: enquiry.id@ubmmedica.com
Design Manager
Hong Kong Vietnam information given in this publication to ensure that it is accurate, the authors,
the publisher and their servants or agents shall not be responsible or in any way
Rowena Sim Kristina Lo-Kurtz, Jacqueline Cheung, Malaysia Nguyen Thi Lan Huong, liable for the continued currency of the information or for any errors, omissions
Designer
Marisa Lam, Miranda Wong Meera Jassal, Lee Pek Lian, Nguyen Thi My Dung or inaccuracies in this publication whether arising from negligence or otherwise
howsoever, or for any consequences arising therefrom. The inclusion or exclusion
Connie Lim Tel: (852) 2559 5888 Irene Lee, Grace Yeoh Tel: (84 8) 3829 7923 of any product does not mean that the publisher advocates or rejects its use
Production
Email: enquiry.hk@ubmmedica.com Tel: (60 3) 7954 2910 Email: enquiry.vn@ubmmedica.com either generally or in any particular field or fields. COPYRIGHT: 2012 UBM
Edwin Yu, Ho Wai Hung, Email: enquiry.my@ubmmedica.com Medica. All rights reserved. No part of this publication may be reproduced, stored
India Europe/USA in a retrieval system or transmitted in any form or by any means, electronic,
Jasmine Chay Monica Bhatia Philippines Kristina Lo-Kurtz mechanical, photocopying, recording or otherwise, in any language, without
Circulation written consent of copyright owner. Permission to reprint must be obtained
Tel: (91 80) 4346 4500 Debbie Pangan, Marian Chua, Philip Tel: (852) 2116 4352 from the publisher. ADVERTISEMENTS are subject to editorial acceptance and
Christine Chok Email: enquiry.in@ubmmedica.com Katipunan Email: enquiry.hk@ubmmedica.com have no influence on editorial content or presentation. UBM Medica does not
Accounting Manager Tel: (63 2) 886 0333 guarantee, directly or indirectly, the quality or efficacy of any product or service
Minty Kwan Japan Email: enquiry.ph@ubmmedica.com
described in the advertisements or other material which is commercial in nature.
Philippine edition: Entered as second-class mail at the Makati Central Post
Advertising Coordinator Mamoru Takagi Office under Permit No. PS-326-01 NCR, dated 9 Feb 2001. Printed by Fortune
Jenny Lim Tel: (81 3) 5562 6961 Singapore Printing International Ltd, 3rd Floor, Chung On Industrial Building, 28 Lee Chung
Email: access-planning@eva.hi-ho.ne.jp Jason Bernstein, Carrie Ong, Street, Chai Wan, Hong Kong.
Published by: Elijah Lee, Reem Soliman
UBM Medica Pacific Limited Korea Tel: (65) 6223 3788
27th Floor, OTB Building Kevin Yi
160 Gloucester Road, Email: enquiry.sg@ubmmedica.com
Wan Chai, Hong Kong Tel: (82 2) 3019 9350
Tel: (852) 2559 5888 Email: inquiry@kimsonline.co.kr
Email: enquiry@jpog.com
MAY/JUN 2012
Vol. 38 No. 3
Review Articles
Paediatrics
P
Continuing Medical Education 2 SK
125
The Journal of Paediatrics, Obstetrics and Gynaecology contains articles under licence from UBM Media LLC. The articles
appearing on pages 4953, and pages 6780 are reprinted with permission of Consultant for Pediatricians. Copyright 2011
UBM Media LLC. All rights reserved.
HSV-1 genital disease. Against HSV-1, infection Harms from breast cancer
GYNAECOLOGY with or without disease, efficacy was 35%. There screening
was no efficacy (-8%) against HSV-2 infection.
Herpes simplex vaccine The HSV-2 vaccine was effective against
HSV-1 genital disease but not against HSV-2 infec-
tion; the reasons are unexplained. An HSV vaccine
suitable for general use is not yet available.
ent part of HER2 and could add to the effectiveness tion of UKs breast screening programme. Later, a
Herpes simplex viruses 1 (HSV-1) and 2 (HSV-2) of trastuzumab. Now, a phase III trial has demon- Cochrane review showed that for every 2,000 wom-
both cause genital infections, and HSV-1 infec- strated this increased effectiveness. At 204 centres en invited for screening over a 10-year period, only
tions are increasingly prevalent. Transmission in 25 countries, a total of 808 women with meta- one would have her life prolonged and ten false-
from mother to newborn infant may cause severe static HER2-positive breast cancer were random- positive women would be treated unnecessarily.
disease. Trials of an HSV-2 glycoprotein D-based ized to treatment with trastuzumab and docetaxel More than 200 women would suffer significant
subunit vaccine have shown around 75% efficacy with or without pertuzumab. Progression-free sur- psychological distress because of false-positive
against HSV-2 disease among women seronegative vival was 18.5 months (pertuzumab) vs 12.4 months results. Now, a new analysis has updated the For-
for both HSV-1 and HSV-2 antibodies. Now, a trial (controls), a significant 38% advantage with pertu- rest Report by presenting data in terms of quality-
in the USA and Canada has surprisingly shown ef- zumab. At an interim analysis of overall survival, adjusted life-years (QALYs).
ficacy against HSV-1 genital disease but not HSV-2 there had been 69 deaths in the pertuzumab group Using data from trial meta-analyses and
disease. and 96 in the control group, an insufficient differ- 1985 English data for breast cancer mortality and
The trial included 8,323 women aged 1830 ence to stop the trial at that point. Toxicity was surgery, two cohorts of 100,000 women aged 50
years who were doubly seronegative (HSV-1 and similar in the two groups. were followed by computer modelling. One cohort
HSV-2). Randomization was to the HSV-2 glycopro- The addition of pertuzumab to trastuzumab was invited for mammographic screening and the
tein D vaccine with alum and 3-0-deacylated mo- and docetaxel improved progression-free survival. other was not. Mortality was reduced, and surgery
nophosphoryl lipid A as an adjuvant or hepatitis A increased in the screening group according to avail-
Baselga J et al. Pertuzumab plus trastuzumab and docetaxel for metastatic
vaccine, at months 0, 1, and 6. The HSV-2 vaccine breast cancer. NEJM 2012; 366: 109119; Gradishar WJ. HER2 therapy able data. The cumulative net QALYs gained from
an abundance of riches. Ibid: 176178 (editorial).
induced ELISA and neutralizing antibodies to HSV- screening were explored in five scenarios. Adding
2. The vaccine efficacy was only 20% against any harms in one of these scenarios halved the gains
genital herpes simplex infection but 58% against in QALYs. Subsequent scenarios showed negative
early years, followed by a net gain in QALYs but at study were smaller than expected.
a slower rate than had been expected.
Seigneurin A et al. Overdiagnosis from non-progressive cancer detected
by screening mammography: stochastic simulation study with calibration
Raftery J, Chorozoglou M. Possible net harms of breast cancer screening: to population based registry data. BMJ 2012; 344 (Jan 14): 15 (d7017);
updated modelling of Forrest Report. BMJ 2012; 344 (Jan 14): 14 (343: d Hackshaw A. Benefits and harms of mammography screening. Ibid: 7 Neoadjuvant chemotherapy plus
7627); Hackshaw A. Benefits and harms of mammography screening. Ibid: (d8279).
344:7 (d8279) (editorial). bevacizumab for breast cancer
Endometriosis
Francesca Raffi, MBChB, MRCOG; Saad Amer, MBChB, MSc, MRCOG, MD
INTRODUCTION
PRESENTATION
Dysmenorrhoea: this is the most common Endometriosis is defined as the presence of endometrial-
like tissue outside the uterine cavity, leading to a chronic
presenting symptom, affecting up to 80% of women inflammatory reaction.
with endometriosis. It is often described as severe
and debilitating and does not respond to simple an-
algesia. The pain classically starts 12 weeks be-
fore the onset of menstruation and gradually wors-
ens, reaching a peak in severity during the first 2
days of the menstrual flow. The pain then gradually
lessens until it disappears at the end of the period.
Non-cyclical pelvic pain: this affects up to
a third of patients with endometriosis. It is often
associated with adhesions, large ovarian endome-
triomas, peritoneal inflammation, and bladder or
bowel endometriosis. Pain resulting from pelvic ad-
hesions is usually provoked or worsened by certain
body movements. Other pains may be triggered by
ovulation, bowel movements (dyschezia), or urina-
tion. All types of non-cyclical pains often worsen
around the time of menstruation.
Deep dyspareunia: this affects about a third
of patients with endometriosis and is mainly seen
in advanced disease with deep infiltrating nodules.
It may be severe enough to force the patient to tendance in adolescents is suggestive of endome-
abstain from intercourse. The pain is usually de- triosis. The presence of the classical patterns of
scribed as a stabbing pain on deep penetration. It pain described above has a sensitivity of 76% and
is triggered by pressure on the scarred utero-sacral a specificity of 58% in detecting endometriosis.
ligaments, recto-vaginal nodules or adhesions ob- Around 30% of adolescents with chronic pelvic pain
literating the pouch of Douglas, or involving the have endometriosis. Adolescents with pelvic pain
ovaries. The symptoms are typically worse before not responding to analgesia and/or the COCP have
menstruation. about a 70% prevalence of endometriosis.
Analysing the pattern of pelvic pain is crucial
DIAGNOSIS in establishing the diagnosis of endometriosis in
adolescents. A pain diary documenting the frequen-
How Would You Diagnose Endometriosis in cy and character of the pain will help to determine
Adolescents? whether the pain is cyclical and if it is related to
Symptoms: adolescents with endometriosis of- bowel or bladder function. A family history of en-
ten present with acyclic and/or cyclic pelvic pain. dometriosis is correlated with a higher likelihood of
Bowel and bladder symptoms are also common in endometriosis in these patients.
this group of patients. Chronic pelvic pain severe Although, endometriosis is the commonest
enough to disrupt normal activities and school at- cause of chronic pelvic pain in adolescents, other
possible endometriosis and can be used as an alter- Box 2. Factors to consider when planning endometriosis
treatment
nate first-line therapy. It improves dysmenorrhoea
and offers a reliable method of contraception. COCP
Age
is generally well tolerated, safe, and inexpensive.
Need to preserve fertility
Another advantage of the pill is that it can be used Need for contraception
as long-term therapy. Tricycling the pill reduces the Presenting symptoms (pain, infertility)
number of bleeds and the associated pain. Possi- Severity of pain and impact on quality of life
Type, extent and location of endometriotic lesions
ble side effects include weight gain, headaches, Involvement of other non-gynaecological systems
nausea, breast enlargement, and depression. Pa- Expertise of clinician
tients should be warned about the increased risk of Availability of resources
Patients preference
thromboembolism during COCP administration.
Medical
Non-hormonal: simple analgesia (paracetamol, NSAID, codeine)
Hormonal treatment: COCP, progestogens, GnRH analogues
is controversial
laparoscopy may be necessary to plan long-term
management of endometriosis, which is potentially
a progressive disease with no cure (Boxes 2 and 3).
CASE 2
In the diagnosis of endometriosis, a pelvic examination is important to rule out other causes of chronic pelvic
pain.
Pelvic examination revealed tenderness affecting completion of GnRH agonist therapy, the symptoms
the right adnexa and the pouch of Douglas. She started to recur. The patient returned to clinic re-
underwent a laparoscopy, which revealed widely questing a hysterectomy as a more definitive treat-
spread deposits of active peritoneal endometriosis ment for her pain.
affecting both ovarian fossae, the utero-sacral liga-
ments, the pouch of Douglas, and the utero-vesical MEDICAL MANAGEMENT
peritoneal fold. Extensive adhesions were also What Is the Current Role of GnRH Agonists
present between the bowel and anterior abdominal in Endometriosis?
wall. All endometriotic deposits were ablated with How Do GnRH Agonists Work and What
electro-diathermy, and the adhesions were divided Should You Warn the Patient About?
with scissors. At post-operative follow-up, her pain How Can You Treat Potential Side Effects
and dyspareunia were much improved. However, 6 and How Long Would You Prescribe the
months later she experienced a recurrence of her Treatment for?
symptoms. She was then counselled regarding GnRH agonists are usually offered as a second-line
further management options and decided to take medical therapy for endometriosis in patients with
a 6-month course of GnRH agonist. This improved severe symptoms not responding to analgesics or
her pain dramatically, and she found the side ef- COCP. They are also a good option for women expe-
fects manageable. However, a few months after the riencing persistence or recurrence of severe symp-
toms after conservative surgery as is in our case. majority of patients will experience a recurrence
GnRH agonists cause an initial stimulation of of symptoms few months after discontinuation of
the GnRH receptors on the gonadotrophs of the an- treatment. GnRH agonists are given as injections
terior pituitary gland, followed by inhibition due to either on a monthly or 3-monthly basis. Side effects
loss of these receptors (known as receptor down- include menopausal symptoms of hot flushes, night
regulation). The resulting fall in follicle-stimulating sweats, mood changes, and vaginal dryness. The
hormone leads to a pseudo-menopausal status with most worrying potential side effect is a 56% loss
of bone mineral density. This limits the safe use of
GnRH agonists to 6 months. The bone loss usually
recovers partially after 612 months of discontinu-
ation of GnRH agonists. The hypo-oestrogenic side
effects and bone mineral loss can be significantly
reduced by the daily administration of tibolone
Surgery is more 2.5 mg as an add-back therapy. In some patients,
it may be necessary to continue the GnRH agonist
effective in
therapy beyond 6 months (unlicensed use). It is rec-
reducing pain ommended in these cases to monitor bone density
in patients with on a yearly base.
more advanced
CONSERVATIVE SURGERY
endometriosis
Compared with medical therapy, surgery offers
a more definitive treatment of endometriosis and
tends to achieve longer lasting improvement of
symptoms. The principles of surgical treatment of
endometriosis include ablation, vaporization or ex-
cision of peritoneal implants, excision or ablation
oestrogen deficiency due to ovarian suppression. of endometriomas, excision of deep infiltrating
Prolonged oestrogen deficiency eventually causes nodular endometriosis, and restoration of pelvic
atrophy of the ectopic endometrial tissue with sub- anatomy by adhesiolysis. The reported incidence
sequent relief of pain. The initial stimulation often of disease recurrence at 5-year follow-up is about
causes worsening of the symptoms during the first 20% for surgery compared with about 50% for
2 weeks of treatment. Patients may also experi- medical treatment. However, about 30% of patients
ence irregular bleeding during the first 2 months of will not experience any improvement in symptoms
GnRH agonist therapy, but amenorrhoea then usu- after surgery. Also of note is that surgery is more
ally ensues. About 80% of patients start to experi- effective in reducing pain in patients with more ad-
ence improvement or complete relief of pain about vanced endometriosis.
4 weeks after the initiation of treatment. This im- A laparoscopic approach for endometriosis
provement will continue throughout the 6-month surgery is superior to laparotomy as it allows a
course of GnRH analogue therapy. However, the more thorough inspection of the pelvis with higher
Surgery offers a more definitive treatment of endometriosis and atypical forms of pelvic endometriosis. Typical
than medical therapy.
peritoneal implants are pigmented lesions includ-
ing dark powder-burn, black puckered, brown, blue-
black, and yellow deposits. Atypical non-pigment-
ed lesions include clear, white or red polypoid or
flame-like lesions. Other lesions include defects
(windows) in the peritoneum. Ovarian endome-
triomas are thick-walled unilocular or multilocular
cysts of varying sizes (usually < 12 cm in diameter)
containing chocolate-coloured fluid due to repeated
bleeding from the endometriotic tissue. They are
typically associated with advanced endometriosis
A laparoscopic approach
for endometriosis surgery
is superior to laparotomy
as it allows a more
magnification, allowing the detection of subtle en- thorough inspection
dometriotic lesions. In addition, laparoscopic sur-
of the pelvis with
gery minimizes trauma to tissues, resulting in less
post-operative adhesion formation. Laparoscopy is higher magnification
also associated with less blood loss, and with its
magnification it allows good detection and control
of small bleeders. From the patients perspective,
laparoscopic surgery shortens hospital stay and al-
lows quicker return to normal activities.
The stage and severity of endometriosis should
be assessed and documented at laparoscopy by de- and extensive adhesions between the affected
scribing the findings and using the revised Ameri- ovary and pelvic sidewall, back of the uterus, and
can Fertility Society classification system (stages broad ligament. However, about 12% of endometri-
IIV). Systematic inspection of the whole pelvis and omas are not associated with adhesions or severe
abdominal cavity is essential. The laparoscopic sur- disease. Deep infiltrating endometriosis (> 5 mm
geon should be familiar with the different typical depth of infiltration) usually affects the recto-vagi-
nal septum and uterosacral ligaments. Utero-sacral Box 4. Indications for surgery for endometriosis
ligament endometriosis is usually characterized by
thickening and firmness of the ligament with vis- Endometriosis detected during diagnostic laparoscopy
ible scarring. It is therefore necessary to palpate Presence of an endometrioma > 3 cm
Deep infiltrating disease causing significant symptoms
the utero-sacral ligament either with the end of a
Endometriosis associated with severe symptoms in subfertile
blunt laparoscopic probe or by vaginal examination. patients
Obliteration of the pouch of Douglas occurs when After failure of medical treatment to control symptoms
the affected rectum is pulled upwards and becomes
fixed to the back of the uterus, causing partial or
complete obliteration of the pouch of Douglas. CASE 3
Minimal-to-mild peritoneal endometriosis can
either be excised or ablated with electro-coagula- A 26-year-old lady presented with a long-standing
tion or laser vaporization. Care should be taken to history of severe dysmenorrhoea and dyspareunia.
avoid thermal damage to the ureters when treating The pattern of dysmenorrhoea was typical of en-
the pelvic sidewall. Both ablation and excision of dometriosis (as described above). She had been try-
mild endometriotic implants have been shown to be ing to conceive for the previous 15 months without
equally effective in improving post-operative pain. success. She had also been troubled with indiges-
Deep infiltrating endometriosis affecting the tion and constipation. Her GI symptoms gradually
utero-sacral ligaments and/or recto-vaginal septum worsened until she became unable to have solid
should be completely excised. food and survived on fluids only. As a result, her
weight dropped dramatically from 58 to 38 kg over
RADICAL SURGERY a period of 6 months.
Pelvic examination revealed a fixed and ret-
This includes total abdominal hysterectomy with roverted uterus, but no recto-vaginal nodules were
or without bilateral oophorectomy. This treatment found.
option should only be considered in patients who A transvaginal ultrasound scan showed a
have completed their family and have had failed thick-walled, 7-cm, right ovarian cyst with internal
medical or conservative surgical treatments. A pre- echoes, suggestive of an endometrioma. A diagnos-
operative trial of GnRH analogues may be helpful tic laparoscopy was performed and showed grade
in determining whether this treatment will be suc- IV endometriosis with extensive adhesions involv-
cessful and whether oophorectomy should also be ing the bowel and completely covering the pelvic
performed. All deep-seated endometriosis should be organs. Only the superficial part of a right-sided
removed during the hysterectomy to prevent remain- ovarian cyst was seen firmly adherent to the bowel,
ing disease from causing persistent pain. Bilateral uterus, and abdominal wall. The tubes and ovaries
salpingo-oophorectomy may result in a better pain could not be visualized. In view of the extent and
relief with reduced chances of further surgery in severity of the endometriosis and the involvement
the future. However, this benefit has to be balanced of the bowel, no treatment was performed on that
against the disadvantage of inducing menopause occasion.
with the need of hormone replacement therapy Post-operatively, a magnetic resonance imag-
(HRT), especially in patients under 40 (Box 4). ing scan was performed showing an 8-cm multi-
vaginal septum endometriosis is very difficult and lostomy may be necessary in severe cases.
requires considerable skill and experience. Tradi-
tionally, this surgery has been performed through CONCLUSION
laparotomy. However, more recently, a laparoscopic
approach has been developed in a few centres. Endometriosis can be a very complex condition to
Whilst laparoscopy offers several advantages over treat, and it is important to tailor the treatment to
open surgery, it takes a considerably longer time, the individual patient. As we have seen, medical
which increases the risk of compartment syndrome treatment may be a very good option for an ado-
(an acute calf muscle ischaemia due to prolonged lescent like Case 1 but would not be appropriate in
pressure within the confined fascial compartment someone seeking to get pregnant like Case 3. More
leading to muscle necrosis). In addition to reducing invasive treatment is necessary if the initial con-
the operating time, open surgery allows careful pal- servative therapy is not effective or if the disease
pation for nodular disease, which is necessary for is more advanced. Again, in these cases, patients
accurate determination of the extent of the disease. wishes must be kept into consideration. A hysterec-
This type of surgery is usually carried out jointly tomy, although a good option for Case 2, would not
with a colorectal surgeon (and sometimes an urolo- be appropriate for Case 1 or 3.
gist) who may not be comfortable performing this
complicated surgery laparoscopically.
The recto-vaginal space is accessed by mobi-
2011 Elsevier Ltd. Initially published in Obstetrics, Gynaecology &
lizing the rectum and the nodules removed until nor- Reproductive Medicine 2011; 21(4):112117.
mal tissue is identified. Depending on the extent of
rectal involvement, removal of endometriotic tissue
from the rectum can be achieved by shaving the an- About the Authors
Francesca Raffi is a Clinical Research Fellow at Royal Derby Hospital,
terior wall, disc resection, anterior wall resection, Derby, UK. Saad Amer is Associate Professor of Obstetrics and Gynae-
or segment resection. Occasionally, a temporary co- cology at Royal Derby Hospital, Derby, UK.
Hyperemesis, Gastrointestinal
and Liver Disorders
in Pregnancy
Clare Cuckson, BA, MB BChir, MRCOG; Sarah Germain, MA, MB BS, DPhil, MRCP
Table 1. Differential diagnosis and relevant investigations of nausea and vomiting in pregnancy
Investigations
Urea and electrolytes, full blood count, liver function tests, thyroid function tests, calcium
Mid-stream urine
Ultrasound scan pelvis
Intravenous fluids
1 L 0.9% normal saline with 20 mmol potassium chloride over 2 hours
1 L 0.9% normal saline with 20 mmol potassium chloride over 4 hours
Followed by
1 L 0.9% normal saline every 8 hours with potassium replacement dependant on serum level
Vitamin supplements
Thiamine PO 50 mg TDS or 100 mg IV in 100 mL normal saline once weekly
or
B vitamins/vitamin C (contains 250 mg thiamine, riboflavin, pyridoxine, nicotinamide, and vitamin C)
Anti-emetics
First-line:
Cyclizine 50 mg PO/IM/IV TDS
Second-line:
Metoclopramide 10 mg PO/IM/IV TDS
Promethazine 25 mg PO Nocte
Domperidone 3060 mg PR BD or 10 mg PO QDS
Prochlorperazine 5 mg PO TDS or 12.5 mg IM/IV TDS; 5 mg TDS PR or 25 mg OD PR
Thromboprophylaxis
Anti-embolic stockings
Low-molecular-weight heparin, eg, enoxaparin 40 mg OD (< 90 kg) or 60 mg OD (> 90 kg)
BD = twice a day; IM = intramuscular; IV = intravenous; nocte = every night; PO = by mouth; PR = per rectum; QDS = four times a day; TDS = three times a day.
Constipation
This is another common condition in pregnancy af-
fecting 40% of women, as physiological changes
lead to decreased colonic motility and pressure of
the gravid uterus on rectosigmoid colon. Risk fac-
tors include dehydration, poor dietary intake, opiate
analgesia, and iron supplements.
Non-pharmacological measures such as in-
creased fluid intake and dietary fibre are usually
sufficient, with temporary cessation of oral iron.
Laxatives may be required if these other measures
fail, and both osmotic (lactulose, magnesium hydro-
chloride) and stimulant (senna, glycerol supposito-
(such as sleeping semi-recumbent and avoiding ries) types are safe.
food and fluids immediately before bed) and phar-
macological measures. Drugs that are safe to use DISORDERS OF THE LIVER AND
in pregnancy are antacids (aluminium salts cause BILIARY TRACT
constipation and magnesium diarrhoea); Antacids
with alginic acid; metoclopramide; sucralfate; H 2- There are several disorders of the liver, which are
receptor blockers (ranitidine is safe but avoid cime- specific to pregnancy and are important to recog-
tidine because of its effect on androgen receptors); nize as they are associated with significant morbid-
and proton-pump inhibitors. Avoid misoprostol as it ity and mortality for the mother and her fetus and
is an abortifacient, and it is also associated with delivery is the only cure. Some pre-existing con-
congenital abnormalities, fetal death, and uterine ditions may only become clinically evident during
perforation. pregnancy, and others such as hepatitis E have a
predilection for pregnant women in whom the prog- Table 3. Swansea criteria for diagnosis of AFLPa six or more of
the following features in the absence of another explanation
nosis is significantly worse.
758%, respectively. Maternal complications in- with this condition are to the fetus and include pre-
clude disseminated intravascular coagulation, renal term delivery, meconium staining of the liquor, and
failure, pancreatitis, and (transient) diabetes insip- intrauterine fetal death, which is reported to be
idus. There is also a risk of progression to hepatic 212% depending on the studies reviewed. The risk
encephalopathy and fulminant liver failure. of stillbirth is difficult to predict despite cardioto-
Management if AFLP presents antenatally, cography monitoring and ultrasound for fetal well-
then coagulopathy and hypoglycaemia should be being. One prospective cohort study of 693 cases of
treated aggressively and delivery expedited. High OC has shown that the risk to the fetus occurs when
dependency unit and/or intensive therapy unit in- the serum bile acids are above 40 mol/L and that
volvement are/is usually required and early liaison there is a 12% increase in fetal complications for
with a specialist liver unit in case of progression to every 1 mol/L increase in the serum bile acid level.
liver failure.
Post delivery, most women recover quickly,
and management is conservative and supportive.
Liver function may take up to 4 weeks to recover,
and liver transplantation should be considered in
those with liver rupture, severe encephalopathy,
The risk of stillbirth is
or failure of liver recovery. The recurrence rate for
AFLP is around 25%, but many women avoid a fur- difficult to predict despite
ther pregnancy. The baby should be screened for cardiotocography monitoring
LCHAD deficiency.
and ultrasound for fetal
Obstetric Cholestasis wellbeing
Features and investigations Obstetric
cholestasis (OC) is a pregnancy-specific condition,
which occurs in approximately 0.7% of pregnant
women in the UK, and the main features are ma-
ternal pruritus and impaired liver function. In most
cases, the serum bile acids are elevated, but de-
rangement in other markers of liver function such as Management involves excluding other
transaminases, bilirubin and -glutamyltransferase causes for liver function derangement as OC is a
also occurs. Other maternal symptoms include stea- diagnosis of exclusion. Itching can be severe, caus-
torrhoea, pale stools, and dark urine. ing marked skin excoriation, insomnia, and mater-
The aetiology of the condition is incompletely nal distress. It is important to take a proper history
understood but is thought to be due to the chole- in these cases as a rash is not a feature of OC and
static effect of oestrogens, which is supported by the patient will report that the itching preceded the
the higher incidence in twin pregnancy and occur- skin changes. Mild symptoms can be managed with
rence of similar symptoms in some individuals tak- antihistamines and emollients containing 12%
ing the oral contraceptive pill. menthol. For more severe cases, ursodeoxycholic
Complications the major risks associated acid is the most effective treatment for ameliorat-
It is important to recognize the liver disorders that are specific to pregnancy because they are associated with
significant morbidity and mortality for the mother and her fetus.
Laxatives may be required if increased fluid intake and dietary tion, clotting, glucose, full blood count and oxygen
fibre fail to relieve constipation in pregnancy.
saturation will help to distinguish those needing
intensive care.
Viral Hepatitis
Viral hepatitis is caused by the hepatitis viruses A,
B, C, D and E and by cytomegalovirus, Epstein-Barr
virus and herpes simplex virus (HSV). The course
of these viruses is usually unaffected by pregnancy
except for hepatitis E and HSV where the outcomes
are likely to be more severe. In general, patients
may be asymptomatic or complain of right upper
quadrant pain, nausea and vomiting, and general
malaise. Transaminases are raised typically > 1,000
IU, but alkaline phosphatase is often normal.
of recent travel to these areas. Most cases are self- Table 4. Differential diagnosis of abnormal liver function in
pregnancy
limiting, but fulminant liver failure can occur. Acute
infection is confirmed by the presence of hepatitis
Viral hepatitis (A, B, C, E) Serology
A IgM antibodies in the serum. Vertical transmis- EBV, CMV, HSV
sion at delivery is rare, but if occurs the neonate Autoimmune hepatitis ANA, anti-LKM antibodies
can be treated with normal immunoglobulin. Primary biliary cirrhosis Anti-mitochondrial
Hepatitis B transmission of hepatitis B antibodies, ANF, anti-sm
occurs mainly by sexual contact or infected blood Autoimmune sclerosing Anti-sm, ANCA
cholangitis
products. Acute infection usually presents with
Wilsons disease Serum copper and caerulo-
mild symptoms. Fulminant liver failure can occur plasmin
in around 1%. Usually less than 5% remain as car- Haemochromatosis Ferritin
riers which is associated with a risk of cirrhosis, Gallstones Ultrasound
chronic active hepatitis, and liver cancer. The risk Fatty liver
of vertical transmission is low unless the mother Cirrhosis
ANA = antinuclear antibodies; ANCA = anti-neutrophil cytoplasmic antibodies; ANF = antinuclear factor;
develops the acute infection during the pregnancy CMV = cytomegalovirus; EBV = Epstein-Barr virus; HSV = herpes simplex virus; LKM = liver-kidney
microsome.
(90% in the third trimester). High vertical transmis-
sion rates also occur in mothers who are positive
for the hepatitis B e antigen which is a marker of
high infectivity. Pregnancy has no effect on the disease; how-
Mode of delivery does not alter the vertical ever, patients are more at risk of OC which is often
transmission rate. Invasive procedures in labour, more severe.
such as applying fetal scalp electrodes or fetal The risk of vertical transmission is low if the
blood sampling, should be avoided. Neonates mother has a low viral titre. Mode of delivery and
should be given hepatitis B immunoglobulin and breastfeeding do not influence the rate of neonatal
vaccinated at birth and usually again at 1 month infection.
and 6 months. Giving this combined regimen pro- Hepatitis E Hepatitis E is spread by the fae-
tects against neonatal infection in 93% of cases. cooral route and, in the non-pregnant population,
Breastfeeding should be encouraged as this also is usually a self-limiting illness. Pregnant women
does not alter the risk of neonatal infection pro- are more severely infected with 20% developing
vided vaccination is given. acute liver failure. The maternal mortality rate is
Mothers with hepatitis B should also be 12 times higher than in the non-pregnant popula-
screened for hepatitis C and human immunodefi- tion. Vertical transmission was approximately 30%
ciency virus and have their baseline liver function in one small study with a fetal mortality rate of 50%
checked. in those affected.
Hepatitis C Hepatitis C is a blood-borne in- Herpes Simplex Virus HSV hepatitis occurs
fection and is common amongst intravenous drug more commonly in pregnant women than the gen-
users. At least 85% of infected individuals will eral population and has a maternal mortality rate
develop chronic liver disease with around 30% de- of 39%. It can occur through primary infection or by
veloping cirrhosis after 10 years. Women should be reactivation of a latent disease and can be caused
under the care of a hepatologist. by serotypes HSV 1 and 2. Mucocutaneous lesions
are present in only 50% of cases. Definitive diag- hood. The incidence of ulcerative colitis is higher
nosis is made on liver biopsy, but computed tomo- in women than in men whereas Crohns disease af-
graphic scan is of value, showing multiple low-den- fects both sexes equally. The course of disease is
sity areas within the liver. Treatment with aciclovir usually unaffected by pregnancy, although Crohns
improves survival and should not be delayed if the may flare post partum. Symptoms suggestive of ac-
diagnosis is suspected. tive disease should be investigated with full blood
The differential diagnosis of abnormal liver count, serum albumin level and stool culture, and
function in pregnancy and a guide to investigations sigmoidoscopy or proctoscopy.
are given in Table 4.
T
he child with a limp is a common problem with broad differential diagnoses, of which
few are true emergencies. This review focuses on the clinical evaluation of children
presenting with a limp, including key elements of the history and examination and ap-
propriate diagnostic tests and management. It also focuses on the more common and important
causes of limp in children.
A limp is defined as a deviation from the normal gait pattern expected for a childs
age.1 It is a common complaint in childhood and was reported to account for four in
every 100 visits to one paediatric emergency department in the USA.2 The conditions to
consider in the differential diagnosis will depend in part on the patients age. Common
conditions leading to a limping child include soft tissue or bone injuries; infection of the
bone, soft tissues or joints; and neuromuscular, congenital, developmental, ischaemic
and neoplastic processes.
A prospective study that evaluated 243 children younger than 14 years of age who
presented to a paediatric emergency department with limp and no history of trauma
showed that 3:
the median age of affected children was 4 years
limp was more common in boys (2:1)
limp was painful in 80% of cases, and pain was localized to the hip in 34% and the
knee in 19% of cases
transient synovitis or irritable hip was the most common cause of limp, accounting
for 40% of all cases.
Although the majority of affected children will have benign, self-limiting causes for
limp, a significant proportion of children will require additional diagnostic studies and
subspecialty care to diagnose and manage more serious underlying conditions.
Important aspects of the history of a limping child disorders and is less likely to present acutely. Pain
that is worse in the morning and associated with
stiffness is suggestive of an inflammatory process,
Age
whereas pain that is worse at the end of the day is
Onset of pain and limp: sudden or insidious, time of day
Any history of trauma, including non-accidental injury
Association with pain and its location, including referred pain
Preceding viral illness, which can precede transient synovitis
Aggravating factors
Functional limitations Three major factors will
Constitutional symptoms, such as fever, weight loss or malaise
cause a child to limp
pain, weakness, or
CAUSES OF LIMPING
Transient Synovitis
The common causes of limp in children are listed in Transient synovitis or irritable hip is the most com-
the box on this page. mon cause of limp in preschool-aged children. It can
Begin the clinical examination by observing the child's gait evated. An ultrasound, if performed, should show a
pattern or posture.
small effusion. Transient synovitis is a self-limited
inflammatory condition that usually resolves within
7 to 10 days. Treatment is rest and analgesia, usu-
ally with a non-steroidal anti-inflammatory drug
(NSAID) such as ibuprofen or naproxen, based on
the severity of the symptoms.
Transient synovitis or
irritable hip is the most
common cause of
limp in preschool-aged
children
conditions, but if the white blood cell count is more Figure 1. Perthes disease in a 4-year-old boy. Note the
flattening of the left femoral head and sclerosis.
than 50,000 cells/mm3 and predominantly neu-
trophils, infection should be presumed. Treatment
of patients with septic arthritis is surgical drain-
age and use of antibiotics (usually flucloxacillin) to
cover infection with Staphylococcus aureus.
The presentation of osteomyelitis overlaps
with that of septic arthritis, and treatment is simi-
lar with empirical antibiotic therapy, usually with
flucloxacillin. Open surgical drainage and washout
may be required if there is evidence of joint in-
volvement or abscess. Discitis, infection of the disc
space, can also present with limp and should be
suspected in younger children who are refusing to
walk and cry when picked up. They may be tender
in the region of the affected disc, usually L1 to L5.
Perthes Disease
Perthes disease is an avascular necrosis of the
femoral head and is seen commonly between the
ages of 4 and 9 years and more often occurs in
boys (Figure 1). The onset is often insidious with Figure 2. Slipped upper femoral epiphysis in the left hip of a
9-year-old girl.
a painless limp and then the development of hip,
groin, lateral thigh or knee pain. On examination,
the patient may have a leg length discrepancy with
decreased abduction and internal rotation of the
hip. X-ray changes vary depending on the stage
of the disease, but there is usually flattening and
fragmenting of the femoral head. A bone scan may
pick up earlier changes. Treatment of patients with
Perthes disease may vary from close observation to
bracing or surgery with the goal being to maintain
range of movement and containment of the femoral
head within the acetabulum.
Osteosarcomas are the most common type of bone tumour seen rotated and shortened. Surgical treatment is often
in children.
needed with fixation of the femoral epiphyses by
pinning.
WHO TO REFER
CONCLUSION
References
1. Thompson GH. Bone and joint disor- rics. 17th ed. Philadelphia: WB Saunders; bance in 425 pediatric patients. Pediatr ing child: epidemiology, assessment
ders. In: Behrman RE, Kliegman RM, Jen- 2004:22512252. Emerg Care 1985;1:710. and outcome. J Bone Joint Surg Br
son HB, eds. Nelson Textbook of Pediat- 2. Singer JI. The cause of gait distur- 3. Fischer SU, Beattie TF. The limp- 1999;81:10291034.
P
2 SK
history of ANH and more accurate antenatal the distribution (segmental or general), degree
diagnosis. of calyceal distension or parenchymal thick-
In our current era, the approach to ANH ness. However, this is the most widely adopted
should have the following goals: accurate quantitative parameter in obstetric practice,
antenatal identification of high-risk ANH; especially outside North America.
and minimal postnatal imaging for low-risk As with most numerical threshold values
patients but aggressive and early surgi- for pathological diagnosis, the choice of the
cal intervention for high-risk uropathies. cut-off point involved a fine balance between
Even though prenatal diagnosis allows for sensitivity and specificity. Studies attempting
the planning of appropriate postnatal care, to define the normal range of APD for a fetus
this benefit should be weighed against undue have found that the maximum dimension of a
Ultrasound makes an excellent screening parental anxiety or even distress. normal renal pelvis at any gestational age is
tool for neonates with ANH. less than 5 mm in 92.7% of cases.1 Therefore,
WHAT CONSTITUTES ANH? a level below 4 mm in the second trimester
INTRODUCTION has been identified as the lower acceptable
Two widely accepted systems based on ultra- limit for a likely normal postnatal outcome.
Antenatal hydronephrosis (ANH) is a general sound images are used internationally for However, there is still controversy as to the
term used to describe the dilatation of the fetal grading the severity of renal pelvis dilatation: threshold value for the third trimester to adopt
renal pelvis and/or its calyces. In pelviectasis, the anteroposterior diameter (APD), a quanti- for predicting postnatal pathology, be it 7 or 9
there is only dilatation of the renal pelvis; tative measurement of the dimension of the mm. A strict criterion of 7 mm on a 33-week
while in caliectasis, there is dilatation of the pelvis; and the Society of Fetal Urology (SFU) gestation ultrasound will lead to a 100%
calyces. ANH is the most commonly diagnosed grading, which is a qualitative observation of detection of all hydronephrosis but also a high
congenital urinary tract anomaly, which is the degree of pelvic and calyceal dilatation. false-positive rate of 3080%.2,3 On the other
detected by prenatal screening in 15% of all The degree of renal pelvic dilatation, however, hand, Mallik and Watson4 illustrated that by
pregnancies. may be modified by the fetus gestational age, increasing the APD cut-off for the third trimes-
In the early years of routine fetal ultra- degree of fetal bladder distension, and mater- ter to 10 mm, it will miss out on 25% of cases
sound screening, almost all cases of ANH nal hydration status. with pelviureteric junction obstruction (PUJO)
were subjected to invasive imaging studies and 50% with vesicoureteral reflux (VUR);
postnatally, followed by a pre-emptive surgical APD Measurement conversely, only 23% with benign dilatation
approach. The management of ANH has since The APD system measures the anteroposterior would be included.
trended towards a more conservative approach diameter in millimetres of the renal pelvis on The third-trimester APD has the highest
over the past two decades. This shift is attrib- the transverse plane at its point of exit from positive predictive value in predicting postnatal
uted to the better appreciation of the natural the kidney. It does not take into account all of uropathies.5 It is thus universally agreed upon
to each kidney studied. The total score ranges In the pre-antenatal screening era, pyelo- ing trend of renal function or progressive renal
from 0 to 9, with the best pathological cut-off plasty was performed mainly for symptomatic dilatation. Randomized trials have so far
value of 6 differentiating between physiologi- kidneys. The concern was that unrelieved indicated that only 1925% of prenatally
cal fetal dilatation and pathological hydrone- obstruction could potentially lead to near-total diagnosed PUJO eventually required surgical
phrosis loss of kidney function. Thus, in the early ante- intervention.26
natal screening period in the 1980s, almost
Fetal Magnetic Resonance Imaging all ANH cases that were diagnosed as pelvi- Transient Hydronephrosis
Although ultrasound remains the modality ureteric junction obstruction were subjected The majority of the patients with ANH
of choice for imaging ANH, fetal magnetic to early pre-emptive pyeloplasty based on (4188%) have a non-pathological dilatation
resonance imaging is beginning to emerge as the treatment philosophy, which was tailored of the kidney that either resolves spontane-
a valuable complementary tool for complex for symptomatic chronic PUJO. The natural ously in the fetus or stabilizes with no further
urological anomalies. It allows for exquisite history of antenatal pelviureteric junction deterioration over time.4,27,28 Therefore, surgi-
demonstration of both normal and abnormal obstruction and the concept of significant cal intervention is not recommended for these
renal anatomy. Fetal magnetic resonance obstruction (ie, obstruction associated with patients. This transient pelvic dilatation, which
imaging is especially valuable in cases when compromised renal functions) soon began to is termed transient hydronephrosis, may be
the ultrasound findings are inconclusive. Its surface in the 1990s. The landmark random-
22
the result of:
use, however, is still fairly limited. ized controlled trial that illustrates the benign 1. Physiologically slow canalization of the
course of antenatal PUJO was published by ureter and maturation of the excretory
AETIOLOGIES OF ANH Dhillon et al from the Great Ormond Street system.
Hospital, London. Patients were randomized
23
2. Transient real impairment to the urinary
The possible postnatal diagnosis of ANH into two arms: 48 children who had pyeloplasty, out-flow giving rise to self-limiting prena-
includes PUJO, transient hydronephrosis, VUR, and 52 who were managed conservatively. tal dilatation. This has been postulated to
non-refluxing megaureter, duplex kidneys with Of the 52 kidneys managed conservatively, result from a delayed maturation of the
ureterocele or ectopic ureter, posterior urethral 9 (17%) had deterioration of function during pelviureteric or vesicoureteric junctions.
valve (PUV), urethral atresia/stenosis, and the observation period. However, 14 showed 3. Extra-renal pelvis.
ureteral obstruction. evidence of resolving obstruction while 29 4. Low-grade transient VUR that resolves
out of 52 (56%) retained stable function spontaneously with no urinary tract infec-
Pelviureteric Junction Obstruction despite radionuclide scans revealing persis- tion episodes.
Pelviureteric junction obstruction is the tent obstruction. Amongst the studies that Even though ureteric canalization is
commonest cause of pathological ANH support initial conservative management were achieved at the end of embryogenesis, matura-
(4060%) with an incidence of 1 in 2,000 those by Koff et al 24,25
on 104 newborns with tion of the ureteric wall continues well beyond
live births. It is three times more common in
21
unilateral severe hydronephrosis who were birth. In a study by Thomas et al29 to monitor
males and may be bilateral in 2025% of cases. managed conservatively. Only 23 required long-term progress of mild pelvic dilatation in
The proposed aetiology includes intramural surgery for decreasing renal function, while 29 children over a mean period of 4.2 years
fibrosis at the pelviureteric junction, abnormally 69% of the hydronephrosis resolved over an (range 1.57.8 years), 69% of the kidneys
high insertion of the ureter, extrinsic compres- average period of 2.5 years with no deteriora- reverted to normal while the remaining 31%
sion from crossing vessels, and adhesion. The tion of renal function. were diminished in size or were unchanged.
classical ultrasound findings are calyceal and The current surgical approach has tended Nevertheless, it remains exquisitely
renal pelvis dilatation in the absence of a towards an initial watchful wait while surgery challenging to differentiate between transient
hydroureter. has been reserved for cases with a deteriorat- hydronephrosis and pathological dilatation
30%, and a ureteral diameter greater than ing lower moiety ureter. If the upper moiety is days, as about 80% of the cases are detected
1.33 cm. We favour a single-stage ureteral
41
of good function, preservation is an option by prenatally. MCU should be performed urgently
re-implantation, likely with ureteral tapering. either cystoscopic incision of the ureterocele at birth to confirm the diagnosis, thus enabling
or resection of the ureterocele followed by early ablation of the PUV or vesicostomy for
Duplex Kidneys With PUJO or Ure- re-implantation of the ureters. Similarly for the decompression of the upper tract. It is essen-
terocele/Ectopic Ureters ectopic ureter, common sheath re-implantation tial that metabolic abnormalities be corrected
Hydronephrosis can affect either the upper or of ipsilateral ureters is the operation of choice as soon as possible and urosepsis should be
lower moiety of the duplex kidney. Obstruction for preservation of the upper moiety. However, prevented.
of the lower moiety is invariably at the level if the upper moiety demonstrates minimal Of those who survive the neonatal
of the pelviureteric junction. The indication for function with a massively dilated ureter, lapa- period, 1730% will eventually develop end-
surgical intervention in this case is similar to roscopic upper hemi-nephroureterectomy is stage renal impairment necessitating dialysis
that of PUJO in a single kidney. The exception proposed. or transplant.44,45 The presence of bilateral VUR
is the technical details of the surgical correc- with recurrent urinary tract infections are poor
tion. For duplex kidneys with low ureteral bifur- PUV and Urethral Atresia prognostic indicators.
cation, the standard dismembered pyeloplasty Posterior urethral valve is the most common
is appropriate. However, for high ureteral bifur- cause of lower urinary tract obstruction in Multicystic Dysplastic Kidney
cation with a short segment of lower moiety neonates, with an incidence of 1 in 5,000 Although strictly not part of the aetiology of
ureter distal to the PUJO, an end-to-side anas- 8,000 live births. The fetus is invariably male.
4
ANH, multicystic dysplastic kidney (MCDK) has
tomosis between the lower moiety pelvis and Typical ultrasound findings are that of bilateral been mistaken for gross hydronephrosis. The
the upper moiety ureter is favoured. hydronephrosis, hydroureters, and distended diagnostic features on ultrasound that must be
Obstruction of the upper moiety of duplex and thick walled urinary bladder with dilata- verified include multiple non-communicating
systems resulting in dilatation of the corre- tion of the posterior urethra. In addition, there randomly distributed cysts of variable sizes,
sponding pelvicalyceal system is caused by is frequently associated renal dysplasia with lack of identifiable renal parenchyma, and
either an ureterocele or a ectopic ureter. The occasional presence of perinephric urinoma a non-dilated ureter. It is well documented
anomaly is identified on antenatal screening or fetal ascites. The high perinatal mortality that MCDK has an excellent potential for
with an incidence of 57%. The diagnosis
4
rate is attributed to the severe oligohydram- spontaneous involution.46 Narchi47 reviewed
can easily be confirmed by the presence of a nios and the resultant pulmonary hypoplasia. 26 published series of MCDK involving 1,115
massively dilated ureter, a duplex kidney, and In the latest annual report of the UK renal children managed conservatively; there were
visualization of a cystic structure within the registry, obstructive uropathy accounted for no cases of malignant change and only six
urinary bladder on ultrasound. Further postna- 16% of children with end-stage renal failure reported cases of hypertension. Ismaili et al48
tal imaging should include micturating cysto- of whom 89% were male with PUV. However,
42
has shown in their study that two successive
gram, dynamic radionuclide scan, and even data from the literature is inconclusive on the normal postnatal ultrasound scans may suffice
magnetic resonance urography. benefit of antenatal drainage. It may increase to rule out clinically significant uropathies of
The condition may emerge as a neona- perinatal survival with improved lung develop- the contralateral kidney.
tal emergency if the ureterocele becomes ment but has not been shown to optimize renal
prolapsed and causes bladder outlet obstruc- prognosis by limiting the degree of congenital POSTNATAL EVALUATION OF
tion. A simple cystoscopic puncture of the renal dysplasia.43 ANH
ureterocele will suffice. Main surgical decision Nevertheless, the classic scenario of
making will depend on the function of the upper neonates with PUV presenting with life- The postnatal evaluation of ANH should follow
moiety and the presence or absence of a reflux- threatening urosepsis is extremely rare nowa- a systematic and comprehensive imaging
sophisticated computer software is essential infants with mild to moderate pyelectasis when of renal damage from infection and neglect.
for these advanced applications. followed up for 2 years. Therefore, it is impor- An antenatal consultation with a paediatric
MRU has been shown to be superior to tant to follow up even the mild and moderate urologist or surgeon may be the key to better
radionuclide studies in distinguishing between ANH postnatally with at least two ultrasound compliance.
pyelonephritis and scarring.52 It is especially examinations. By repeating the ultrasound,
informative for duplex system with minimal the predictability for significant uropathies CONCLUSION
functioning upper moiety. MRU, therefore, has has been shown to improve to a sensitivity of
the potential to replace ultrasound and renal 96%, specificity of 76%, positive predictive Over the past two decades, the natural history
radionuclide scintigraphy in the investigation value of 72%, and a negative predictive value of ANH has become better understood and
of ANH. The major impediment with MRU is of 97%. appreciated. Prenatal diagnosis has undoubt-
the excessively long image acquisition time However, for infants with moderate to edly improved the survival outcome and
and its extreme sensitivity to motion artifact. severe hydronephrosis, a more intense and reduced the morbidities of most congenital
This translates to the necessity of general sophisticated protocol must be employed, ie,
urological anomalies.
anaesthesia for neonates, infants and even urgent MCU followed by early diuretic renal
However, perfect and cost-effective
younger children. scan.54
management strategy guidelines derived
Conversely, dilatation detected in the
from evidence-based research are not yet
POSTNATAL IMAGING ALGO- second trimester but resolved by the third
available. Understandably, randomized trials
RITHMS FOR ANH trimester may still have a 12% risk of signifi-
in the realm of maternalfetal medicine and
cant anomalies. Therefore, parents should be
paediatrics are at best difficult if not impos-
Controversy still exists in the literature regard- advised on the possibility of late presentation
sible to develop and execute. Therefore,
ing the extent of postnatal imaging for mild of PUJO.
the next best option may be the setting up
ANH (SFU grades 1 and 2). We recommend Prophylactic use of antibiotics is not
of a collaborative registry on ANH between
the European Society of Paediatric Radiology universally agreed upon. Prenatal screening
regional centres and even countries.
imaging recommendations in paediatric urora- has been responsible for a drastic decrease in
diology37: two postnatal ultrasounds 4 weeks urinary tract infection, but occasional infection About the Authors
apart as screening. It has been shown by the still occurs. Dr Yap is Senior Consultant, Department of Paediatric
Surgery, KK Womens and Childrens Hospital, Singapore.
Brussels Free University Perinatal Nephrol- To ensure that antenatal detection and Associate Professor Jacobsen is Senior Consultant,
ogy Study Group that significant nephrou-
53
postnatal follow-up go hand in hand, all efforts Department of Paediatric Surgery, and Chairman, Divi-
sion of Surgery, KK Womens and Childrens Hospital,
ropathies were diagnosed in 39% of their 213 must be made to educate parents on the risk Singapore.
Acknowledgement
This paper was made possible through a collaboration between KK Womens and Childrens Hospital (KKH) and the Journal of Paedi-
atrics, Obstetrics and Gynaecology. KKH is the largest medical facility in Singapore which provides specialized care for women, babies
and children.
References
1. Scott JE, Wright B, Wilson G, et al. Measuring findings with infant outcome. Am J Obstet Gynecol 4. Mallik M, Watson AR. Antenatally detected urinary of systematic screening for minor degrees of fetal
the fetal kidney with ultrasonography. Br J Urol 1991;165:384388. tract abnormalities: more detection but less action. renal pelvis dilatation in an unselected population.
1995;76:769774. 3. Toiviainen-Salo S, Garel L, Grignon A, et al. Fetal Pediatr Nephrol 2008;23:897904. Am J Obstet Gynecol 2003;188:242246.
2. Corteville JE, Gray DL, Crane JP. Congenital hydronephrosis: is there hope for consensus? Pediatr 5. Ismaili K, Hall M, Donner C, et al; Brussels Free A complete list of references can be obtained upon
hydronephrosis: correlation of fetal ultrasonographic Radiol 2004;34:519529. University Perinatal Nephrology study group. Results request to the editor.
Program pendidikan kedokteran berkelanjutan ini dipersembahkan oleh Medical Progress Institute,
sebuah institusi yang didedikasikan untuk pembelajaran CME, bekerjasama dengan Ikatan Dokter
Indonesia.
Setelah membaca artikel Current Management of Antenatal HydronephrosisAn Update, jawab
pertanyaan berikut kemudian kirimkan dengan menggunakan formulir jawaban yang sudah disediakan ke
CME Medical Progress/ Journal of Paediatrics, Obstetrics & Gynaecology, untuk mendapatkan 2 SKP.
P
Artikel CME: 2 SK
1. The APD system takes into account all of the distribution, degree of calyceal distension or parenchymal thickness.
2. The second-trimester APD has the highest positive predictive value in predicting postnatal uropathies.
3. The SFU grading system has been shown to have good intra-rater reliability but only modest inter-rater agreement.
4. It has been shown that ANH detected in early pregnancy may stabilize or even resolve completely.
5. The classical ultrasound findings of PUJO are calyceal and renal pelvis dilatation in the absence of a hydroureter.
6. Surgical intervention is recommended for patients with transient hydronephrosis.
7. The AUA panel recommends that MCU be performed for all infants with both mild and high-grade postnatal
hydronephrosis.
8. Ultrasound is an excellent screening tool for neonates with ANH and for the planning of subsequent postnatal
management.
9. MCU should not be offered to infants with postnatal pelvis dilatation of more than 7 mm in any one of two consecutive
postnatal ultrasound examinations performed 1 month apart.
10. It is important to follow up even the mild and moderate ANH postnatally with at least two ultrasound examinations.